---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-177650"
form_type: "8-K"
ticker: "CTMX"
cik: "0001501989"
company_name: "CytomX Therapeutics, Inc."
filed_at: "2022-06-21T23:59:59+00:00"
generated_at: "2026-06-25T00:21:33.066307+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# CytomX shareholders elect McCarthy and Mohindru as directors, ratify E&Y, approve exec comp

## Summary
- Class I directors Sean McCarthy and Mani Mohindru elected with ~68% of votes cast.
- Ratification of Ernst & Young as auditor for FY2022 passed with 99.95% of votes cast.
- Non-binding advisory vote on named executive officer compensation approved with ~93% support.
- All proposals passed; broker non-votes recorded for directors and say-on-pay only.

## SEC filing metadata
- accession: 0001193125-22-177650
- form_type: 8-K
- ticker: CTMX
- cik: 0001501989
- company_name: CytomX Therapeutics, Inc.
- filed_at: 2022-06-21T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1501989/000119312522177650/0001193125-22-177650-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1501989/000119312522177650/d331581d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-177650
- JSON: https://secwatch.observer/filing/0001193125-22-177650.json
- Plain text: https://secwatch.observer/filing/0001193125-22-177650.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.